ARNA and OREX Related HeadlinesGo Back
- Arena Pharma (ARNA) Peers Trade Lower in Sympathy (OREX) (VVUS)
- Wells Fargo Comments on Orexigen Therapeutics (OREX) PDUFA Data Change
- Orexigen (OREX), Arena (ARNA) in Focus Following VIVUS' (VVUS) Q4 Results
- WallachBeth Starts Orexigen (OREX) at Buy; Sees Contrave With Edge Over Peers (ARNA) (VVUS)
- VIVUS, Inc. (VVUS) Sees CHMP Feedback on Qsiva Resubmission as 'Generally Positive'
- Analyst Sees Positive Reimbursement Trends for Obesity Drugs (VVUS) (ARNA) (OREX)
- Orexigen (OREX) Plans Resubmission of Contrave NDA by Year End 2013